Department of Orthopedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Anticancer Drugs. 2021 Jun 1;32(6):602-613. doi: 10.1097/CAD.0000000000001034.
Long non-coding RNAs have the regulatory roles in different kinds of human cancers. The key point of this study was to research the functional mechanisms of urothelial carcinoma associated 1 (UCA1) in the development of osteosarcoma. Quantitative real-time PCR was adopted for the expression detection of UCA1, microRNA-513b-5p (miR-513b-5p) and E2F transcription factor 5 (E2F5). The target relation was verified via dual-luciferase reporter assay and RNA pull-down assay. Cell proliferation was evaluated using Cell Counting Kit-8 and colony formation assays. Transwell assay was applied to assess cell migration and invasion. Western blot was performed for protein examination. Xenograft experiment was used to explore the effect of UCA1 on osteosarcoma in vivo. UCA1 expression was enhanced while miR-513b-5p was refrained in osteosarcoma tissues and cells. MiR-513b-5p was a target of UCA1. Inhibition of UCA1 or overexpression of miR-513b-5p suppressed osteosarcoma cell proliferation, migration and invasion. E2F5 was identified as a downstream gene of miR-513b-5p. MiR-513b-5p inhibitor or E2F5 overexpression rescued the progression inhibition of osteosarcoma by UCA1 knockdown, and UCA1 regulated E2F5 and Cyclin E expression by targeting miR-513b-5p. Downregulation of UCA1 restrained the tumorigenesis of osteosarcoma in vivo through the miR-513b-5p/E2F5 axis. Collectively, knockdown of UCA1 inhibited tumorigenesis and metastasis of osteosarcoma via regulating the miR-513b-5p/E2F5 axis. UCA1 might be a biological indicator in the progression and treatment of osteosarcoma.
长链非编码 RNA 在人类多种癌症中具有调控作用。本研究的重点是研究尿路上皮癌相关 1(UCA1)在骨肉瘤发生发展中的功能机制。采用定量实时 PCR 检测 UCA1、微小 RNA-513b-5p(miR-513b-5p)和 E2F 转录因子 5(E2F5)的表达。通过双荧光素酶报告基因检测和 RNA 下拉实验验证靶关系。采用细胞计数试剂盒-8 和集落形成实验评估细胞增殖。Transwell 实验用于评估细胞迁移和侵袭。Western blot 用于蛋白检测。异种移植实验用于研究 UCA1 在体内对骨肉瘤的影响。骨肉瘤组织和细胞中 UCA1 表达增强,miR-513b-5p 表达受到抑制。miR-513b-5p 是 UCA1 的靶基因。抑制 UCA1 或过表达 miR-513b-5p 抑制骨肉瘤细胞增殖、迁移和侵袭。E2F5 被鉴定为 miR-513b-5p 的下游基因。miR-513b-5p 抑制剂或 E2F5 过表达挽救了 UCA1 敲低对骨肉瘤进展的抑制作用,UCA1 通过靶向 miR-513b-5p 调节 E2F5 和细胞周期蛋白 E 的表达。下调 UCA1 通过 miR-513b-5p/E2F5 轴抑制骨肉瘤的体内致瘤性。总之,通过调节 miR-513b-5p/E2F5 轴,下调 UCA1 抑制骨肉瘤的发生和转移。UCA1 可能是骨肉瘤进展和治疗的生物学标志物。